DJIA 16,540.45 -102.56 -0.62%
NASDAQ 4,803.29 -25.03 -0.52%
S&P 500 1,976.16 -12.71 -0.64%
market minute promo


1.11 -0.04 (-3.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $1.11 -3.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.11
Previous Close $1.15
Daily Range $1.10 - $1.15
52-Week Range $0.94 - $4.82
Market Cap $115.5M
P/E Ratio -1.13
Dividend (Yield) $0.00 (0.0%)
Volume 359,189
Average Daily Volume 1,769,284
Current FY EPS -$0.59




Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary

The 3 Most Disappointing Drug Launches of All Time

Treatments with huge promise don't always pan out the way you'd expect.

Why VIVUS (VVUS) Could Shock the Market Soon

Orexigen: Contrave Wins Another Sales Week - Don't Bank On Impressive Numbers

Vivus Hovers Near 52-Week Lows - Qsymia Sales Not Helping

This Is a Concern That Amgen Investors Shouldn't Take Lightly

Most investors are focused on the upcoming PDUFA decision for PCSK9 inhibitor Repatha, but this should be a far bigger concern.

Orexigen- Contrave Sales Win The Week But Still Flatter Than Needed

Arena - Belviq Sales Dip Again. We Have Seen The Peak In 2015

Vivus (VVUS) Flagged As Strong On High Volume

Stocks Trading Near Their 52-Week Lows: 4 Hot Picks

VIVUS Inc. (VVUS) in Focus: Stock Jumps 5.4%

See More VVUS News...

VVUS's Top Competitors

VVUS $1.11 (-3.48%)
Current stock: VVUS
JNJ $94.45 (-0.76%)
Current stock: JNJ
NVS $97.73 (-0.63%)
Current stock: NVS
RHHBY $34.08 (-0.25%)
Current stock: RHHBY